• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2,4-二氨基喹唑啉和2,4-二氨基蝶啶类似物与恶性疟原虫二氢叶酸还原酶的结合模式:分子对接研究

Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies.

作者信息

Adane L, Bharatam P V

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar-160 062, India.

出版信息

Indian J Pharm Sci. 2010 May;72(3):324-33. doi: 10.4103/0250-474X.70478.

DOI:10.4103/0250-474X.70478
PMID:21188041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3003165/
Abstract

A molecular docking study was carried out on 28 compounds belonging to 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs using Glide, FlexX and GOLD programs and the X-ray crystallographic structures of the quadruple mutant (1J3K:pdb) and wild type (1J3I:pdb) Plasmodium falciparum dihydrofolate reductase enzyme. The experimental conformation the bound ligand WR99210 was precisely reproduced by the docking procedures as demonstrated by low (<2.00 Å) root-mean-square deviations. The results indicated that most of the compounds dock into the active sites of both the wild type and quadruple mutant P. falciparum dihydrofolate reductase enzymes. Visual inspection of the binding modes also demonstrated that most of the compounds could form H-bond interactions with the key amino acid residues (Asp54, Ile14 and Leu/Ile164) and with better docking scores than the bound compound (5). Their long side chains orient in the hydrophobic portion of the active site which is occupied by trichloro aryloxy side chain of WR99210 (5). Thus, avoid potential steric clashes with Asn108 (mutated from Ser108). Such a clash is known to be responsible for the resistance of the P. falciparum to pyrimethamine and cycloguanil.

摘要

使用Glide、FlexX和GOLD程序以及恶性疟原虫二氢叶酸还原酶四重突变体(1J3K:pdb)和野生型(1J3I:pdb)的X射线晶体结构,对属于2,4-二氨基喹唑啉和2,4-二氨基蝶啶类似物的28种化合物进行了分子对接研究。对接程序精确再现了结合配体WR99210的实验构象,低均方根偏差(<2.00 Å)证明了这一点。结果表明,大多数化合物对接至野生型和四重突变型恶性疟原虫二氢叶酸还原酶的活性位点。结合模式的可视化检查还表明,大多数化合物能够与关键氨基酸残基(Asp54、Ile14和Leu/Ile164)形成氢键相互作用,并且对接分数优于结合化合物(5)。它们的长侧链朝向活性位点的疏水部分,该部分被WR99210的三氯芳氧基侧链占据(5)。因此,避免了与Asn108(由Ser108突变而来)的潜在空间冲突。已知这种冲突是恶性疟原虫对乙胺嘧啶和环氯胍产生抗性的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/4e2ed86af08c/IJPhS-72-324-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/d10bbc318bbf/IJPhS-72-324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/1a5e69fb4f5f/IJPhS-72-324-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/a95f6be26bf9/IJPhS-72-324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/4dd7867d5321/IJPhS-72-324-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/4e2ed86af08c/IJPhS-72-324-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/d10bbc318bbf/IJPhS-72-324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/1a5e69fb4f5f/IJPhS-72-324-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/a95f6be26bf9/IJPhS-72-324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/4dd7867d5321/IJPhS-72-324-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc75/3003165/4e2ed86af08c/IJPhS-72-324-g005.jpg

相似文献

1
Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies.2,4-二氨基喹唑啉和2,4-二氨基蝶啶类似物与恶性疟原虫二氢叶酸还原酶的结合模式:分子对接研究
Indian J Pharm Sci. 2010 May;72(3):324-33. doi: 10.4103/0250-474X.70478.
2
Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.基于形状和化学特征的 3D 药效团模型生成和虚拟筛选:鉴定潜在的恶性疟原虫 DHFR 酶抑制剂先导化合物。
Chem Biol Drug Des. 2010 Jan;75(1):115-26. doi: 10.1111/j.1747-0285.2009.00908.x. Epub 2009 Nov 5.
3
Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives.用乙胺嘧啶衍生物对恶性疟原虫四重突变二氢叶酸还原酶抑制作用的建模
J Comput Aided Mol Des. 2008 Jan;22(1):29-38. doi: 10.1007/s10822-007-9152-9. Epub 2007 Dec 11.
4
Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.来自对乙胺嘧啶敏感和耐药的恶性疟原虫的刚性和柔性抗叶酸剂与二氢叶酸还原酶之间相互作用的分子动力学
Chem Biol Drug Des. 2014 Oct;84(4):450-61. doi: 10.1111/cbdd.12334. Epub 2014 Jun 4.
5
Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.计算机辅助 1H-咪唑-2,4-二胺衍生物的分子设计,作为潜在的恶性疟原虫 DHFR 酶抑制剂。
J Mol Model. 2011 Apr;17(4):657-67. doi: 10.1007/s00894-010-0756-y. Epub 2010 Jun 5.
6
In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.针对野生型和突变型恶性疟原虫二氢叶酸还原酶的计算机筛选。
J Mol Graph Model. 2008 Apr;26(7):1145-52. doi: 10.1016/j.jmgm.2007.10.006. Epub 2007 Oct 18.
7
Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.乙胺嘧啶类似物作为人类疟原虫中二氢叶酸还原酶双突变体和四突变体的强效抑制剂。
Org Biomol Chem. 2003 Mar 21;1(6):960-4. doi: 10.1039/b211636g.
8
Flexible diaminodihydrotriazine inhibitors of Plasmodium falciparum dihydrofolate reductase: Binding strengths, modes of binding and their antimalarial activities.疟原虫二氢叶酸还原酶的柔性二氨基二氢三嗪抑制剂:结合强度、结合模式及其抗疟活性。
Eur J Med Chem. 2020 Jun 1;195:112263. doi: 10.1016/j.ejmech.2020.112263. Epub 2020 Mar 25.
9
Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.乙胺嘧啶、环氯胍、WR99210及其类似物与恶性疟原虫二氢叶酸还原酶的相互作用:抗叶酸耐药性的结构基础。
Bioorg Med Chem. 2000 May;8(5):1117-28. doi: 10.1016/s0968-0896(00)00022-5.
10
Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.喀麦隆雅温得疟疾的分子流行病学。VI. 恶性疟原虫二氢叶酸还原酶-胸苷酸合成酶基因的序列变异及对乙胺嘧啶和环氯胍的体外抗性
Am J Trop Med Hyg. 2000 Feb;62(2):271-6. doi: 10.4269/ajtmh.2000.62.271.

引用本文的文献

1
Quinoline conjugates for enhanced antimalarial activity: a review on synthesis by molecular hybridization and structure-activity relationship (SAR) investigation.用于增强抗疟活性的喹啉缀合物:分子杂交合成及构效关系(SAR)研究综述
Am J Transl Res. 2025 Feb 15;17(2):1335-1375. doi: 10.62347/TTHX6526. eCollection 2025.

本文引用的文献

1
3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.环鸟苷衍生物作为 A16V+S108T 突变型恶性疟原虫二氢叶酸还原酶抑制剂的 3D-QSAR 分析。
J Mol Graph Model. 2009 Nov;28(4):357-67. doi: 10.1016/j.jmgm.2009.09.001. Epub 2009 Sep 6.
2
Resistance to antimalarial compounds: methods and applications.抗疟化合物的耐药性:方法与应用
Drug Resist Updat. 2009 Feb-Apr;12(1-2):42-50. doi: 10.1016/j.drup.2009.01.001. Epub 2009 Mar 13.
3
Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases.
环氯胍衍生物与野生型及抗药相关突变型恶性疟原虫二氢叶酸还原酶之间的相互作用。
J Comput Aided Mol Des. 2009 Apr;23(4):241-52. doi: 10.1007/s10822-008-9254-z. Epub 2009 Jan 21.
4
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.利用结构分析、计算机筛选和意外发现来鉴定耐药恶性疟原虫的新型抑制剂。
ACS Chem Biol. 2009 Jan 16;4(1):29-40. doi: 10.1021/cb8002804.
5
Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.恶性疟原虫二氢叶酸还原酶(DHFR)酶抑制剂分析中的建模与信息学
Curr Med Chem. 2008;15(16):1552-69. doi: 10.2174/092986708784911551.
6
Particular interaction between pyrimethamine derivatives and quadruple mutant type dihydrofolate reductase of Plasmodium falciparum: CoMFA and quantum chemical calculations studies.乙胺嘧啶衍生物与恶性疟原虫四重突变型二氢叶酸还原酶之间的特定相互作用:比较分子场分析和量子化学计算研究。
J Enzyme Inhib Med Chem. 2009 Apr;24(2):471-9. doi: 10.1080/14756360802201223.
7
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.恶性疟原虫全球种群中两个氯喹抗性位点的遗传变异不一致模式。
Antimicrob Agents Chemother. 2008 Jun;52(6):2212-22. doi: 10.1128/AAC.00089-08. Epub 2008 Apr 14.
8
QSAR using evolved neural networks for the inhibition of mutant PfDHFR by pyrimethamine derivatives.使用进化神经网络的定量构效关系研究:乙胺嘧啶衍生物对突变型恶性疟原虫二氢叶酸还原酶的抑制作用
Biosystems. 2008 Apr;92(1):10-5. doi: 10.1016/j.biosystems.2007.10.005. Epub 2007 Nov 17.
9
In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.针对野生型和突变型恶性疟原虫二氢叶酸还原酶的计算机筛选。
J Mol Graph Model. 2008 Apr;26(7):1145-52. doi: 10.1016/j.jmgm.2007.10.006. Epub 2007 Oct 18.
10
Malaria - an overview.疟疾——概述
FEBS J. 2007 Sep;274(18):4670-9. doi: 10.1111/j.1742-4658.2007.05997.x.